Viking Therapeutics (VKTX) Q2 2023 Earnings

26JulConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.26
-0.24
-0.21
-0.19

Details

Expected EPS
-0.19
Actual EPS
-0.19
Surprise EPS
0
Surprise Percent
+0%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.19 per share for Q2 2023.

0 Comments

Share your thoughts